Last reviewed · How we verify
NCT05688917
Green Coffee Effect on Metabolic Syndrome
NA trial testing Green coffee been extract in Supportive Care in 160 participants. Completed in 30 September 2022.
1 September 2022
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 160 |
| Start date | 3 September 2020 |
| Primary completion | 1 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Green coffee been extract
- Placebo
Conditions studied
- Supportive Care — all drugs for Supportive Care →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Obesity — all drugs for Obesity →
- Hypertension — all drugs for Hypertension →
Sponsor
Tanta University
Who can join
Adults 20 to 60, any sex, with Supportive Care or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study aimed to investigate the effect of green coffee bean extract (GCBE) on the inflammatory biomarkers in obese patients with a metabolic syndrome via analyzing some inflammatory biomarkers as resistin, TNF-α, total sialic acid, homocysteine, high sensitivity C-reactive protein (hs-CRP) and anti-inflammatory cytokine, adiponectin
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of green coffee on miR-133a, miR-155 and inflammatory biomarkers in obese individuals.
Khedr NF, Zahran ES, Ebeid AM, Melek ST, et al · · 2024 · cited 2× · PMID 39468643 · DOI 10.1186/s13098-024-01478-7
Verify or expand the search:
- PubMed search for NCT05688917
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Supportive Care
Currently open trials in the same condition.
- NCT07505498 — Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set · recruiting
- NCT06604455 — Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime · NA · recruiting
- NCT06767826 — The Effect of Care Based on the Salutogenesis Model · NA · active not recruiting
- NCT06237179 — Behavioral Exercise Training to Reduce Cardiovascular Disease Risk · Phase 1, PHASE2 · recruiting
- NCT06663514 — SupporTive Care At Home Research for Patients with Progressive Neurologic Disease Patients (STAHR-Neuro) (HOMECARE) · NA · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05688917 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 26 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05688917.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing